Evidence map›Paper›PMID 37745021›Full record

ArticleEClinicalMedicine2023

Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study.

Arianna Dagliati, Zachary H Strasser, Zahra Shakeri Hossein Abad, Jeffrey G Klann, Kavishwar B Wagholikar, Rebecca Mesa, Shyam Visweswaran, Michele Morris, Yuan Luo, Darren W Henderson and 11 more

Abstract read
In one paragraph

Article in EClinicalMedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. From Stagnation to Strategy: Challenges in Advancing Long COVID Research.Journal of evaluation in clinical practice · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Arianna DagliatiDepartment of Electrical Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
Zachary H StrasserDepartment of Medicine, Massachusetts General Hospital, Boston, United States.
Zahra Shakeri Hossein AbadUniversity of Toronto, Dalla Lana School of Public Health, Toronto, Canada.
Jeffrey G KlannDepartment of Medicine, Massachusetts General Hospital, Boston, United States.
Kavishwar B WagholikarDepartment of Medicine, Massachusetts General Hospital, Boston, United States.
Rebecca MesaDepartment of Electrical Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
Shyam VisweswaranDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, United States.
Michele MorrisDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, United States.
Yuan LuoDepartment of Preventive Medicine, Northwestern University, Chicago, United States.
Darren W HendersonUniversity of Kentucky, Center for Clinical and Translational Science, Lexington, United States.
Malarkodi Jebathilagam SamayamuthuDepartment of Biomedical Informatics, University of Pittsburgh, Pittsburgh, United States.
Bryce W Q TanNational University Hospital, Singapore Department of Medicine, Singapore.
Guillame VerdyBordeaux University Hospital, IAM Unit, Bordeaux, France.
Gilbert S OmennUniversity of Michigan, Department of Computational Medicine and Bioinformatics, Internal Medicine, Human Genetics, and School of Public Health, Ann Arbor, United States.
Zongqi XiaUniversity of Pittsburgh Department of Neurology, Pittsburgh, United States.
Riccardo BellazziDepartment of Electrical Computer and Biomedical Engineering, University of Pavia, Pavia, Italy.
Consortium for Clinical Characterization of COVID-19 by EHR (4CE),
Shawn N MurphyDepartment of Neurology, Massachusetts General Hospital, Boston, United States.
John H HolmesUniversity of Pennsylvania Perelman School of Medicine, Department of Biostatistics, Epidemiology, and Informatics, Institute for Biomedical Informatics, Philadelphia, United States.
Hossein EstiriDepartment of Medicine, Massachusetts General Hospital, Boston, United States.
Consortium for Clinical Characterization of COVID-19 by EHR (4CE)

Funding

Strategic Vision & Impact on Environmental HealthP30ES017885 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Dana Dolinoy · 2011 to 2026
$21.3M
Temporal Phenotypes and Risk Models for the Post-COVID Syndrome and its sub-typesR01AI165535 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Hossein Estiri, SHAWN N MURPHY · 2022 to 2026
$4.1M
British Heart Foundation FS/19/52/34563NIAID NIH HHS R01 AI165535NIEHS NIH HHS P30 ES017885
6 · The paper itself

Abstract

Background: Characterizing Post-Acute Sequelae of COVID (SARS-CoV-2 Infection), or Methods: We conducted a retrospective multi-centre observational cohort study, leveraging longitudinal electronic health record (EHR) data of 30,422 patients from three healthcare systems in the Consortium for the Clinical Characterization of COVID-19 by EHR (4CE). From the total cohort, we applied a deductive approach on 12,424 individuals with follow-up data and developed a distributed representation learning process for providing augmented definitions for PASC sub-phenotypes. Findings: Our framework characterized seven PASC sub-phenotypes. We estimated that on average 15.7% of the hospitalized COVID-19 patients were likely to suffer from at least one PASC symptom and almost 5.98%, on average, had multiple symptoms. Joint pain and dyspnea had the highest prevalence, with an average prevalence of 5.45% and 4.53%, respectively. Interpretation: We provided a scalable framework to every participating healthcare system for estimating PASC sub-phenotypes prevalence and temporal attributes, thus developing a unified model that characterizes augmented sub-phenotypes across the different systems. Funding: Authors are supported by National Institute of Allergy and Infectious Diseases, National Institute on Aging, National Center for Advancing Translational Sciences, National Medical Research Council, National Institute of Neurological Disorders and Stroke, European Union, National Institutes of Health, National Center for Advancing Translational Sciences.

Indexed as

COVID-19Electronic health recordsPASCPost-acute sequelae of SARS-CoV-2SARS-CoV-2

Identifiers

PMID37745021
PMCPMC10511779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.